Cancer Immunotherapy Articles & Analysis
42 articles found
Ongoing studies are exploring their potential in cancer immunotherapy, gene therapy, and as platforms for diagnostic applications. ...
These chemokines protein allows researchers to study the functional dynamics of chemokine-receptor interactions in controlled environments, facilitating the development of targeted therapies for a range of diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions. One of the most significant applications lies in cancer ...
A single missing fucose residue can enhance antibody-dependent cellular cytotoxicity by 50-fold, revolutionizing cancer immunotherapy approaches. The analytical challenge is immense. ...
Understanding CAR-T Therapy CAR-T therapy involves extracting T-cells from a patient's blood, modifying them in a laboratory to express specific receptors that can recognize cancer cells, and infusing them back into the patient. This immunotherapy has shown remarkable success, particularly in hematologic malignancies such as acute lymphoblastic leukemia and ...
Advancements such as dental diode lasers, portable mesh nebulizers, and urology operation techniques are transforming patient care. Additionally, individualized cancer immunotherapy is paving the way for personalized treatment strategies, while research on immune acquisition and multiple sclerosis continues to evolve. ...
As the fight against cancer progresses, there is an increasing demand for novel and personalized therapeutic approaches. Traditional cancer treatments often lack the specificity necessary to target malignant cells while sparing healthy tissues. ...
Alfa Cytology unveils advanced cancer immunotherapy development services. Alfa Cytology, a renowned services supplier in oncology, has recently introduced its groundbreaking cancer immunotherapy development services. ...
Immunotherapy in Leukemia Treatment Immunotherapy represents a paradigm shift in the treatment of leukemia. Unlike conventional treatments that target both healthy and cancerous cells, immunotherapy empowers the body's immune system to recognize and combat cancer cells more selectively and effectively. ...
The emergence of chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of certain cancers, providing a promising targeted approach to eliminate cancer cells. ...
Breast cancer is a type of cancer that begins in the cells of the breast. It can occur in both men and women but is more common in women. ...
This technology is being used to advance our understanding of tumor immunology, support immunotherapy approaches, and discover new cancer biomarkers. Applications of Luminex Technology in Oncology Research In recent years, Luminex technology has been used to profile cytokines in cancer patients, providing valuable insights into the complex ...
This technology is being used to advance our understanding of tumor immunology, support immunotherapy approaches, and discover new cancer biomarkers. Applications of Luminex Technology in Oncology Research In recent years, Luminex technology has been used to profile cytokines in cancer patients, providing valuable insights into the complex ...
This can be a protein or patch that is overexpressed on the face of cancer cells, for illustration, making it an ideal target for antibody remedy. ...
These mRNA-loaded LNPs deliver specific mRNA to the liver for the treatment of various liver-related diseases, including infectious diseases, liver fibrosis, cancer, and genetic disorders. 2) Spleen or lung targeting LNP: Researchers at the University of Texas Southwestern Medical Center reported that selective organ targeting capability can be achieved by altering the ...
Further complexity arises as cancer cells also express the adenosine A1 receptor (ADORA1) and A3 receptor (ADORA3). ...
Eugene Shenderov, the lead author of the study, stated that the use of B7-H3-targeted immunotherapy in prostate cancer is feasible and safe, with preliminary data showing potential clinical activity. ...
The company has recently launched TCR-seq, a powerful service that enables rapid and efficient analysis of T-cell receptor (TCR) diversity and clonality, providing critical support for immune and cancer research. As immunotherapy gains widespread use, increasing attention is being focused on T-cell clone diversity and clonality, which is crucial for evaluating ...
Summary In this Cell Patterns publication, Ozette co-founders and collaborators at the Cancer Immunotherapy Trials Network (CITN) outline a novel method of analysis of single cell data, FAUST, and validate the multiple potential applications. The paper tackles 2 important problems: 1) analysis of complex single cell datasets; 2) prediction of response to ...
Targeting or using these cytokines as therapeutic agents has shown potential in allergy, immunodeficiency, autoimmunity, and cancer ...
The advent of immunotherapies for cancer, and more recently of cellular immunotherapies, has substantially altered the treatment landscape. ...